Compare Cytokinetics Inc (CYTK) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Toronto-Dominion Bank — how do they compare? Cytokinetics Inc trades at $76.75 (market cap $10.63B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 18.9× Cytokinetics Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | TD | |
|---|---|---|
Market Cap | $10.63B | $200.48B |
Sector | Technology | Financials |
52-Week High | $87.26 | $124.80 |
52-Week Low | $34.31 | $72.85 |
Enterprise Value | $10.74B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
